Care4Living: Expert Services for Biopharmaceutical Manufacturers

Care4Living Oy is proud to be part of the LifeFactFuture (LFF) consortium, a pioneering initiative that unites Finland’s leading life science manufacturers, technology companies, and academic researchers. Based in Turku, Care4Living specializes in fermentation-based biopharmaceuticals, providing end-to-end solutions for the development and production of pharmaceutical ingredients. With a strong commitment to innovation, efficiency, and quality, we play a crucial role in enhancing Finland’s global leadership in life science manufacturing.

Innovative Solutions for a Dynamic Industry

At Care4Living, we provide expert services to manufacturers of fermentation-derived bioactive small molecules. With over 40 years of experience in fermentation-based API manufacturing, we help our clients establish efficient, reliable manufacturing processes that fully comply with good manufacturing practice (GMP) standards. We collaborate closely with the University of Turku’s Antibiotic Biosynthesis Engineering group, combining academic knowledge with industrial expertise to push the boundaries of biomanufacturing through process innovation and genetic engineering.

Driving Digital Transformation in Bioprocessing

As a member of the LFF consortium, we are dedicated to harnessing digital technologies to optimize biomanufacturing processes. Moving forward, we believe digitalization will be a key factor in improving efficiency, scalability, and product quality in this sector.

We recognize the power of collaboration and cutting-edge research, which is why we are excited to be part of the LFF program. This partnership perfectly aligns with our ongoing commitment to driving digital transformation within the biopharmaceutical industry.

As a service provider, staying ahead of developments in the manufacturing sector is essential for us. By doing so, we ensure that we consistently offer high-quality services that meet the evolving needs of our clients. Integrating data-driven decision-making into our operations is becoming increasingly vital. Whether optimizing industrial workflows or facilitating seamless technology transfer between our team and clients, digitalization helps accelerate time-to-market for biopharmaceutical products, keeping our customers competitive in a fast-paced industry.

Shaping a Sustainable Future

Sustainability is at the heart of our company values. Biomanufacturing offers notable advantages in cost reduction, energy efficiency, and waste minimization when compared to conventional chemical manufacturing processes. At Care4Living, we are dedicated to reducing the environmental impact of pharmaceutical manufacturing by promoting innovative bioprocessing methods. Through the digitalization of manufacturing processes, we aim to maximize efficiency and minimize environmental footprints, aligning with global goals of sustainability and resource efficiency.

A Vision for Global Biopharmaceutical Leadership

Through our participation in the LifeFactFuture program, Care4Living is working alongside industry leaders to help foster a thriving life science manufacturing ecosystem in Finland. Our expertise, combined with our unique role as a service provider, enables us to offer innovative solutions and drive progress in data-driven biopharmaceutical production. Together with our
partners, we are working to establish Finland as a global hub for cutting-edge biopharmaceutical manufacturing, ultimately benefiting patients worldwide and advancing the industry as a whole.

William Eccleshall
Business Development Specialist, Care4Living Oy